Manufacturability and functionality assessment of different formats of T-cell engaging bispecific antibodies
ABSTRACTT-cell-engaging bispecific antibodies (T-bsAbs) are promising immunotherapies for cancer treatment due to their capability of redirecting T-cells toward destroying tumor cells. Numerous T-bsAb formats have been developed, each with advantages and disadvantages in terms of developability, imm...
Saved in:
Main Authors: | Han Ping Loh (Author), Farouq Bin Mahfut (Author), Serene W Chen (Author), Yuhan Huang (Author), Jianxin Huo (Author), Wei Zhang (Author), Kong Peng Lam (Author), Shengli Xu (Author), Yuansheng Yang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer
by: Tian Huan, et al.
Published: (2023) -
Bispecific antibodies in cancer immunotherapy
by: Eva Dahlén, et al.
Published: (2018) -
Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017) -
Characterization of a novel bispecific antibody targeting tissue factor-positive tumors with T cell engagement
by: Zhidi Pan, et al.
Published: (2022) -
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
by: Amelia C. McCue, et al.
Published: (2024)